Pfizer Ltd.

Financial

	Pfizer	Wockhardt	JB Chem & Pharma
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	8.7 %	10.6 %	10.1 %
Financials
5 yr Average ROE	18.39 %	-3.81 %	19.44 %
5yr average Equity Multiplier	1.28	2.26	1.5
5yr Average Asset Turnover Ratio	0.6	0.39	0.79
5yr Avg Net Profit Margin	24.04 %	-4.46 %	16.41 %
Price to Book	6.18	6.12	8.18
P/E	33.94	0.0	42.6
5yr Avg Cash Conversion Cycle	-2.02 Days	-118.47 Days	19.31 Days
Inventory Days	49.44 Days	68.12 Days	51.72 Days
Days Receivable	26.74 Days	71.63 Days	63.93 Days
Days Payable	81.1 Days	260.3 Days	85.63 Days
5yr Average Interest Coverage Ratio	170.95	-0.67	65.09
5yr Avg ROCE	23.56 %	-1.45 %	23.24 %
5yr Avg Operating Profit Margin	30.56 %	3.11 %	23.72 %
5 yr average Debt to Equity	0.0	0.71	0.08
5yr CAGR Net Profit	65.36 %	46.24 %	15.23 %
5yr Average Return on Assets	14.39 %	-1.84 %	13.06 %
Shareholdings
Promoter Holding	63.92 %	49.09 %	47.84 %
Share Pledged by Promoters	0.0	18.24 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	-18.04 %	-6.16 %
Change in Mutual Fund Holding (3 Yrs)	3.65 %	7.53 %	1.99 %

Business

	Pfizer	Wockhardt	JB Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0	Product Wise Break-Up API 0 CDMO 0 Formulation exported 0 Domestic formulation 0 Pharmaceutical 100.0 Pharmaceutical 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 2.0 Contract Manufacturing 13.59 Formulations 29.72 Domestic Formulations 54.69 Pharmaceuticals 0 Pharmaceutical 0
Location Wise Break-Up	Location Wise Break-Up India 96.14 Rest of the World 3.86 Europe 0 USA 0 Russia 0 South Africa 0	Location Wise Break-Up Europe 0 South Africa 0 USA 0 India 21.89 Rest of the World 78.11 Russia 0	Location Wise Break-Up Europe 0 South Africa 0 USA 0 India 54.32 Rest of the World 45.68 Russia 0